2016 Report on Economic Impact of Bay Area Life Science Startups

From the new report from California Life Sciences Institute on the economic strength/aspects of Bay Area life science startups: "OVERVIEW Pre-Series A life science companies in the Bay Area are significantly impacting the local and state economy. This is the key finding of a survey of 137 Bay Area life science startups conducted by the California [...]

June 7th, 2016|

Bridging Kraków and San Francisco

Big3Bio Spotlight: Bridging Kraków and San Francisco Selvita, the largest the largest drug discovery company in Central and Eastern Europe, has just recently opened its West Coast US office in the San Francisco Bay Area. Selvita provides integrated drug discovery services for medium and large biotech and pharmaceutical companies. It has also an early proprietary oncology [...]

March 21st, 2016|

The Big3Bio Event Preview – EPPICon 2016

It all begins with accurate diagnostics. Discovery of accurate biomarkers triggers the development of new therapeutic drugs as well as companion patient side diagnostic tools, and advances and miniaturization in digital health technology are now leading the democratization of diagnostics by placing these critical tools in the form of wearables and cloud-connected home devices in [...]

March 6th, 2016|

The California Life Sciences Industry: A Powerful Economic Engine

California Life Sciences Association (CLSA) and PwC US have released the 2016 California Life Sciences Industry Report, which indicates that California’s life sciences sector had a profound impact on the state’s economy, "showing industry increases in the areas of sector employment growth, wages, research funding and life sciences venture investment." “Our latest report paints a vivid picture of California’s 2,848 [...]

November 13th, 2015|

Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA - California’s first statewide trade group for biotech   Chapter [...]

October 12th, 2015|

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part [...]

September 28th, 2015|

QB3’s Quick Pitch Competition

QB3 held its first annual tech showcase, QB3 Quick Pitch, Tuesday night to a full house at Byers Auditorium. After a keynote from Corey Goodman of venBIO, 12 companies pitched their solutions to judges and the audience. From an SF Business Times article prior to the event: "The 12 companies for the first workshop, selected from [...]

December 10th, 2014|

Curium Launches at UCSF with Bay Area Entrepreneurs Panel

By Dr. Karen Ring, Big3Bio Events Correspondent With an overabundance of PhD’s in an environment of dwindling academic jobs, graduate students and postdocs are opting for less traditional pathways to achieve scientific success -- this transition from academic to entrepreneur was the topic of discussion at the launch of Curium last night at UCSF. Curium [...]

October 28th, 2014|

Special Feature: Q&A With Menghis Bairu, CEO of Serenus Biotherapeutics

Dr. Menghis Bairu is Founder, Chairman, and CEO of Sereneus Biotherapeutics, a specialty biopharmaceutical bringing innovative therapies to Sub-Saharan African markets. Before founding Serenus, Dr. Bairu concurrently served as EVP, Chief Medical Officer & Head of Global Development at Elan plc and president and CEO of Speranza Therapeutics, Elan’s wholly owned subsidiary formed to develop [...]

June 20th, 2014|